Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A.
Freund, Brian; Schwartz, Marvin.
; 4(3): 159-65, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14622713
Botulinum toxin type A therapy for cervical dystonia.
Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
Botulinum toxin for motor and phonic tics in Tourette's syndrome.
Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis.
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease.
Open-label trial of ranolazine for the treatment of paramyotonia congenita.
Botulinum toxin for myofascial pain syndromes in adults.